Strides Pharma Science Limited STAR

Latest filings

• Routine15 2 Nov, 16:39 · BSE
  Transcript of Earnings Call pertaining of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026
• Routine15 30 Oct, 16:23 · BSE
  Newspaper Advertisement - Unaudited Financial Results for the quarter and half year ended September 30, 2026
• Routine15 30 Oct, 13:14 · NSE
  Link of Recording
• Routine15 30 Oct, 13:11 · BSE
  Audio Recording of Earnings Call pertaining to unaudited Financial Results for the quarter and half year ended September 30, 2026
• Management change70 29 Oct, 19:01 · NSE
  Appointment of Biren Gabhawala as Non- Executive Independent Director of the company w.e.f. November 01, 2026.
• Routine15 29 Oct, 18:57 · NSE
  Allotment of 7500 Shares.
• Routine15 29 Oct, 18:57 · BSE
  Earnings presentation for the quarter and half year ended September 30, 2026.
• General30 29 Oct, 18:47 · NSE
  A press release dated October 29, 2026, titled "Strides Delivers Strong Performance with Q2FY27 Revenue at ₹14,297m, Grew 17% YoYEx-US Markets Up 31% YoY; EBITDA Up 8% YoY to ₹2,509m, Crossing ₹2,500m in a Quarter for the First Time".
• Results73 29 Oct, 18:44 · BSE
  Financial Results for the quarter and half year ended Sept 30, 2026
• Results73 29 Oct, 18:43 · NSE
  , the financial results for the period ended September 30, 2026.

Shown 15 minutes after publication. Real time with Pro.